Always up to date.
 

Our goal is to develop procedure and anatomy specific devices that lead in collaboration with our customers to predictable and superior treatment outcomes. Read on to learn more about our solutions, priorities, partnerships and how we create sustainable value with our teams.

Page 1 of 23.

Publication of Medartis 2024 half-year results

Medartis reports 13% revenue growth on Group level, driven by strong regional growth in the US (21%) and EMEA (18%) – improvement of EBITDA* margin to 17%

Read more

Matthias Schupp appointed as CEO of Medartis

Medartis today announced that its Board has appointed Matthias Schupp to the position of CEO, joining Medartis by the beginning of November. Matthias will succeed Christoph Brönnimann, who will ensure...

Read more

Medartis announces resignation of CEO Christoph Brönnimann

Medartis announces that its CEO, Christoph Brönnimann, has decided to resign from his position and leave the company to pursue other opportunities. Christoph will continue to lead Medartis until a...

Read more

Page 1 of 23.